Prospera Financial Services Inc lowered its stake in Cigna Group (NYSE:CI – Free Report) by 55.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,931 shares of the health services provider’s stock after selling 3,701 shares during the period. Prospera Financial Services Inc’s holdings in Cigna Group were worth $848,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also made changes to their positions in the company. Oppenheimer & Co. Inc. raised its holdings in Cigna Group by 10.1% in the third quarter. Oppenheimer & Co. Inc. now owns 11,857 shares of the health services provider’s stock valued at $3,418,000 after acquiring an additional 1,085 shares in the last quarter. Linden Thomas Advisory Services LLC raised its holdings in shares of Cigna Group by 8.6% in the 3rd quarter. Linden Thomas Advisory Services LLC now owns 3,243 shares of the health services provider’s stock valued at $935,000 after purchasing an additional 258 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its position in shares of Cigna Group by 44.0% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 38,320 shares of the health services provider’s stock worth $11,046,000 after purchasing an additional 11,711 shares during the last quarter. Candriam S.C.A. grew its stake in shares of Cigna Group by 3.0% during the third quarter. Candriam S.C.A. now owns 77,163 shares of the health services provider’s stock worth $22,242,000 after purchasing an additional 2,214 shares in the last quarter. Finally, Roman Butler Fullerton & Co. increased its holdings in Cigna Group by 17.0% in the third quarter. Roman Butler Fullerton & Co. now owns 16,352 shares of the health services provider’s stock valued at $4,891,000 after buying an additional 2,370 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of analysts have issued reports on the company. Mizuho set a $325.00 price target on Cigna Group in a report on Friday, January 9th. Deutsche Bank Aktiengesellschaft boosted their target price on Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a research note on Tuesday, February 10th. Robert W. Baird cut their price objective on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a report on Thursday, December 11th. UBS Group restated a “buy” rating and issued a $375.00 target price on shares of Cigna Group in a report on Monday, February 9th. Finally, Guggenheim reiterated a “buy” rating and set a $318.00 price target on shares of Cigna Group in a research note on Monday, February 2nd. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $330.00.
Cigna Group Trading Up 1.3%
Shares of Cigna Group stock opened at $291.35 on Monday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.74. The company has a market capitalization of $77.83 billion, a P/E ratio of 13.14, a PEG ratio of 1.01 and a beta of 0.27. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The company’s fifty day moving average is $276.85 and its two-hundred day moving average is $283.57.
Cigna Group (NYSE:CI – Get Free Report) last announced its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping the consensus estimate of $7.88 by $0.20. The business had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.
Cigna Group Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be issued a $1.56 dividend. The ex-dividend date of this dividend is Thursday, March 5th. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. Cigna Group’s dividend payout ratio is presently 27.23%.
Cigna Group Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Articles
- Five stocks we like better than Cigna Group
- This $15 Stock Could Go Down as the #1 Stock of 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- America’s 1776 happening again
- They just tried to kill gold
- Your Bank Account Is No Longer Safe
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
